CRIS Current Research Information System

BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.572
EU - Europa 23.725
AS - Asia 21.709
AF - Africa 1.270
SA - Sud America 1.232
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 17
Totale 74.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.317
IT - Italia 8.235
VN - Vietnam 6.600
SG - Singapore 5.556
CN - Cina 5.007
GB - Regno Unito 4.429
DE - Germania 2.224
SE - Svezia 2.167
HK - Hong Kong 1.575
FR - Francia 1.361
UA - Ucraina 1.113
IN - India 1.102
RU - Federazione Russa 970
BR - Brasile 845
IE - Irlanda 702
NL - Olanda 595
CH - Svizzera 420
ZA - Sudafrica 398
TG - Togo 375
JP - Giappone 360
EE - Estonia 333
FI - Finlandia 307
JO - Giordania 231
CI - Costa d'Avorio 220
BG - Bulgaria 218
KR - Corea 200
AR - Argentina 157
CA - Canada 141
PH - Filippine 138
BD - Bangladesh 121
TH - Thailandia 109
BE - Belgio 106
IR - Iran 102
SC - Seychelles 102
AT - Austria 93
GR - Grecia 84
PL - Polonia 81
ES - Italia 77
TR - Turchia 75
MX - Messico 72
EC - Ecuador 68
ID - Indonesia 62
TW - Taiwan 59
IQ - Iraq 57
UZ - Uzbekistan 54
SA - Arabia Saudita 52
PK - Pakistan 44
NG - Nigeria 43
MY - Malesia 41
CL - Cile 40
CO - Colombia 38
LB - Libano 32
HR - Croazia 29
RO - Romania 25
AU - Australia 24
CZ - Repubblica Ceca 23
IL - Israele 23
PE - Perù 21
EG - Egitto 20
NP - Nepal 20
PY - Paraguay 20
TN - Tunisia 20
VE - Venezuela 20
LT - Lituania 19
AL - Albania 18
ET - Etiopia 18
MA - Marocco 18
PT - Portogallo 18
HU - Ungheria 15
DZ - Algeria 13
OM - Oman 13
AE - Emirati Arabi Uniti 12
UY - Uruguay 12
KE - Kenya 11
CR - Costa Rica 10
KZ - Kazakistan 10
AZ - Azerbaigian 9
EU - Europa 9
RS - Serbia 9
BO - Bolivia 8
SK - Slovacchia (Repubblica Slovacca) 8
DK - Danimarca 7
MN - Mongolia 7
PS - Palestinian Territory 7
DO - Repubblica Dominicana 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
LU - Lussemburgo 5
LV - Lettonia 5
NO - Norvegia 5
SI - Slovenia 5
SM - San Marino 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
JM - Giamaica 4
PA - Panama 4
UG - Uganda 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
Totale 74.479
Salva come PNG Salva come JPEG
Città #
Southend 3.832
Singapore 3.750
Fairfield 2.728
Ashburn 2.581
Chandler 2.123
Dong Ket 1.542
Hong Kong 1.492
Woodbridge 1.362
San Jose 1.226
Ho Chi Minh City 1.200
Wilmington 1.177
Houston 1.164
Seattle 1.160
Santa Clara 1.150
Hanoi 1.125
Cambridge 1.014
Princeton 937
Ann Arbor 875
Dublin 692
Jacksonville 657
Boardman 592
Beijing 591
Rome 580
Milan 529
Hefei 526
Bologna 513
Lauterbourg 432
Padova 422
Nanjing 419
Westminster 398
Lomé 374
Los Angeles 348
Bern 330
Tokyo 310
Berlin 276
Helsinki 264
Dallas 234
Amman 229
Abidjan 220
Sofia 215
Jinan 213
Buffalo 209
New York 208
Shenyang 200
Saint Petersburg 198
Verona 195
Florence 186
Turin 186
Da Nang 185
Palermo 181
San Diego 179
Haiphong 169
Changsha 162
Naples 140
Seoul 140
Medford 134
Guangzhou 131
Hebei 131
Mülheim 129
Nanchang 126
Munich 125
Frankfurt am Main 122
Redondo Beach 117
Shanghai 113
Tianjin 108
Council Bluffs 102
Brussels 98
Bari 94
Dearborn 94
São Paulo 93
Zhengzhou 89
Redmond 88
Des Moines 84
London 77
Redwood City 76
Mahé 74
Bremen 70
Jiaxing 66
Chicago 64
Norwalk 63
Paris 63
Can Tho 62
Ningbo 61
Falkenstein 60
Wuhan 60
Hải Dương 59
Biên Hòa 58
Bengaluru 56
Hangzhou 56
Catania 55
Genoa 54
Amsterdam 53
Toronto 52
Orem 51
Phoenix 50
Nuremberg 49
Olalla 49
Mountain View 48
Haikou 46
Lanzhou 45
Totale 45.895
Salva come PNG Salva come JPEG
Nome #
La cardiomiopatia cirrotica. 2.732
L’ipotesi unificante sulla regolazione del volume dei fluidi corporei. Fisiologia e fisiopatologia dell’omeostasi idrosalina, con particolare riguardo allo scompenso cardiaco e alla cirrosi epatica. 2.091
Cirrosi epatica e sue complicanze 791
L’arterializzazione della vena porta per insuffcienza epatica acuta 700
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 478
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 424
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 361
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 360
L’albumina nelle malattie del fegato. 326
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 293
Hyponatremia in patients with cirrhosis of the liver 276
g-hydroxybutyrate as a treatment for alcoholism. 266
Patologie alcol-relate e trattamento dell’alcolismo. 263
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 260
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 260
Alcol, sindrome feto-alcolica, apparato ematopoietico, muscolo-scheletrico, respiratorio, cute e reni. 258
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection. 257
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 253
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 252
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 251
Adaptive response in Hepatitis B virus infection 250
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 249
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 246
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 243
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 241
Mutations in the E2-PEPHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma. 240
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 239
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 239
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 238
L’ipotesi unificante sulla regolazione del volume dei fluidi corporei. Fisiologia e fisiopatoloiga dell’omeostasi idrosalina, con particolare riguardo allo scompenso cardiaco e alla cirrosi epatica. 238
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 236
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 232
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 229
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 227
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 227
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 226
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation. 224
Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. 223
A novel model of CCl4-induced cirrosi with ascites in the mouse. 222
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 221
Acute alcohol intoxication. 220
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 218
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 216
Art in hospital: its impact on the feelings and emotional state of patients admitted to an Internal Medicine Unit. 216
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 216
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 216
Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. 215
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 213
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 213
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 213
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 211
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 211
Alcohol and viral hepatitis: a mini-review. 211
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 209
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 208
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 208
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 206
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 206
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 205
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
L’iponatremia nel paziente con cirrosi epatica. 204
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 203
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 203
Clinical indications for the albumin use: Still a controversial issue. 203
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 203
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 203
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 202
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 201
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 199
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 199
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 198
Vitamins in the treatment of chronic viral hepatitis. 198
Duodenal histology in patients with celiac disease after a gluten-free diet 197
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 197
Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. 197
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 197
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 197
Assorbimento e metabolismo dell’etanolo. 196
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 194
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 194
Cardiac electrophysiological abnormalities in patients with cirrhosis. 194
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 194
Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG 194
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 194
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 193
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 193
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 193
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 192
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) 191
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 191
Recent advances in the natural history of hepatocellular carcinoma. 191
Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation. 190
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 189
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 189
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 189
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 188
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 188
Gamma hydroxybutirric acid (GHB) withdrawal does not occur at therapeutic dosage. 187
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 187
Totale 27.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.196 0 0 0 0 0 0 0 0 0 379 406 2.411
2021/20229.160 881 414 551 780 764 492 306 572 351 549 2.106 1.394
2022/20239.778 968 1.374 494 1.169 571 766 362 545 1.609 347 835 738
2023/20243.737 257 502 241 336 306 560 245 328 168 285 239 270
2024/202510.323 444 1.696 885 875 1.796 530 619 338 221 681 288 1.950
2025/202619.450 1.510 1.668 1.926 1.456 2.348 1.309 2.363 1.047 4.309 1.514 0 0
Totale 75.577